Podcast
MSL Talk: Tom Caravela, Sarah Snyder
HOLD MY BEER… I’m Going to be an MSL
Summary
In this episode, Lana Lucidi shares her journey from early career roles to becoming a Medical Science Liaison. She delves into her transition process, highlighting the importance of mentorship, networking, and leveraging transferable skills. Lana addresses common challenges faced when pursuing an MSL role, particularly navigating job descriptions and targeting the right companies. She offers valuable advice for aspiring MSLs, emphasizing the significance of building expertise and confidence, especially when engaging with Key Opinion Leaders (KOLs). The episode concludes with reflections on the MSL role, the impact of the MSL Talk podcast, and words of encouragement for those on the MSL path.
My guest this week is Lana Luccitti, Medical Science Liaison with Topcon Health who discusses how it is possible to land an MSL role without a Doctorate.
Lana shares…
👉 What made her want to be an MSL
👉 The first thing she did in her MSL Search
👉 The frustrations she had along the way
👉 What helped her stand out from others
👉 Most important advice she can offer
Medical Science Liaison, career transition, mentorship, networking, transferable skills
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Sarah Snyder
Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Social Media Listening Evolved
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO